Apogem Capital’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-561,309
Closed -$1.05M 138
2022
Q2
$1.05M Buy
+561,309
New +$4.41M 0.95% 27
2022
Q1
Sell
-347,977
Closed -$881K 179
2021
Q4
$881K Sell
347,977
-150,000
-30% -$1.57M 0.58% 61
2021
Q3
$1.27M Hold
497,977
0.81% 30
2021
Q2
$1.18M Sell
497,977
-9,281
-2% -$94.8K 0.75% 35
2021
Q1
$1.3M Buy
+507,258
New +$4.45M 0.88% 30

Other funds holding BCS

Apogem Capital's BCS Position: Q3 2022 in Review

Apogem Capital sold out of Barclays (BCS) in Q3 2022, closing a stake of 561,309 shares — an estimated $1.05M sold.

Apogem Capital first reported a position in BCS in Q1 2021 and held it in 5 quarters. The position peaked at $1.3M in Q1 2021. 273 funds tracked by Wall St. Rank hold BCS as of Q3 2022.

  • Apogem Capital reported no remaining Barclays position as of Q3 2022 after selling out during the quarter.
  • Apogem Capital sold 561,309 Barclays shares in Q3 2022, an estimated $1.05M.
  • Apogem Capital first reported a position in Barclays in Q1 2021 and held it in 5 quarters.
  • Apogem Capital's Barclays position peaked at $1.3M in Q1 2021.
  • 273 funds tracked by Wall St. Rank held Barclays as of Q3 2022.

Based on Apogem Capital's 13F filing for Q3 2022, filed 14 Nov 2022.